This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Edward D. Frohlich, MD; Richard A. Cooper, MD; Edmund J. Lewis, MD

Arch Intern Med. 1984;144(7):1441-1444.

Abstract
• The pharmacologic profile of the angiotensin—converting enzyme inhibitor, captopril, is described. After reviewing the total clinical experience of captopril from the world literature and manufacturer's files, a small subgroup of clinically complex patients at particular risk of side effects and in whom the drug must be used with caution is characterized. Evidence is available that demonstrates that lower doses (150 mg/day or less, with modest doses of diuretic agents) are effective in both short- and long-term therapy, while the incidence of side effects is substantially reduced. With this background information, the benefit-risk ratio is substantially improved and the use of captopril as a primary agent in the management of hypertension may be considered.

(Arch Intern Med 1984;144:1441-1444)

Author Affiliations
From the Alton Ochsner Medical Foundation, New Orleans (Dr Frohlich); the Hematology-Oncology Section, University of Pennsylvania Hospital, Philadelphia (Dr Cooper); and the Department of Medicine, Rush-Presbyterian—St Luke's Medical Center, Chicago (Dr Lewis).

Footnotes
Accepted for publication Nov 16,1983.

Reprint requests to Education and Research Division, Alton Ochsner Medical Foundation, 1516 Jefferson Hwy, New Orleans, LA 70121 (Dr Frohlich).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Differential Exercise Effects of Captopril and Nadolol in Patients with Essential Hypertension
Kostis et al.
ANGIOLOGY 1992;43:647-652.
ABSTRACT  

Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor Therapy: A Review of the Literature and Pathophysiology
Israili and Hall
ANN INTERN MED 1992;117:234-242.
ABSTRACT  

Combination of Converting Enzyme Inhibitor With Diuretic for the Treatment of Hypertension
Townsend and Holland
Arch Intern Med 1990;150:1175-1183.
ABSTRACT  

Effect of Enalapril in Subjects With Hypertension Associated With Moderate to Severe Renal Dysfunction
Reams and Bauer
Arch Intern Med 1986;146:2145-2148.
ABSTRACT  

Cough Associated With the Use of Captopril
Sesoko and Kaneko
Arch Intern Med 1985;145:1524-1524.
ABSTRACT